Eiger BioPharmaceuticals, Inc. (EIGR) earnings
Quarterly and annual EIGR reports and results, each read against the price at its own news timestamp. Back to the EIGR overview →
5 measured EIGR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K/A Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.99% | -5.94% | |
| Form NT 10-K Eiger BioPharmaceuticals For: Dec 31 | SEC filing · Form NT | -10.99% | -7.80% | |
| Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -3.00% | -10.03% | |
| Form 10-Q Eiger BioPharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -3.00% | -10.03% |
Keep exploring
More EIGR: analyst actions → · SEC filings → · EIGR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DEMANT HLDG U/ADR (WILYY) | 48 | 0.00% | 18% |
| HLS THERAPEUTICS INC (HLTRF) | 47 | 0.00% | 24% |
| OTSUKA HOLDINGS CO ADR (OTSKY) | 45 | -0.06% | 39% |
| Cipher Pharmaceuticals Inc (CPH_TSE) | 43 | -0.35% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.